Choose   Change
BGI Advancing Genomics Together
BGI Advancing Research
BGI Advancing Drug Discovery
BGI Advancing Healthcare
News
/by

China National Genebank Officially Opens

Official opening of the China National GeneBank (CNGB) marks a new phase in Chinese-International genomics collaboration, providing scientists from across the world with access to one of the world's most comprehensive and sophisticated biorepositories, with the goal of enabling breakthroughs in human health research and contributing to global biodiversity conservation efforts.
Spotlight
/by

Enter Our Competition and Win $5000 of NGS Services!

A unique chance at ASHG to help unlock the potential of your genomics research! Sign up at www.bgi.com/us/unlockthecode and get your unique code. Come to our booth #323-325 at the ASHG conference to see if your code unlocks our genomics treasure chest to win $5,000 of FREE NGS services, from one of our ISO, CAP or CLIA certified laboratories around the world.

Discover BGI’s Exome Sequencing Service

– 100 bp and 150bp Paired End sequencing options available
– Guaranteed ≥ 80% of bases with quality score of ≥Q30
– CAP compliant facility in Hong Kong
– US FDA 21 CFR Part 11 compliant processes

ASHG Conference
Events
/by

BGI Will Be Exhibiting At ASHG.

BGI will be exhibiting at the American Society of Human Genetics (ASHG) conference taking place in Vancouver, Canada, 18-22 October. We'll be at booth 323-325. Discover more about our wide range of sequencing services on the industry’s latest NGS platforms or come and speak to one of our knowledgeable staff members about your sequencing project.

Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.

About BGI

BGI was founded in 1999 as a nonprofit research organization. Over the years, BGI has grown into a multinational genomics company with significant global operations and a wide variety of next generation sequencing (NGS) services including whole genome sequencingexome sequencing and RNA sequencing. With more than 5,000 employees across the globe and R&D, manufacturing, and commercial operations around the world, BGI is committed to providing genomics solutions to address the research, pharmaceutical, and clinical markets while utilizing the power of NGS technology in order to improve human health and empower large-scale human, plant, and animal genomics research.

________________________________________________________________________________________

9

Offices

On 5

Continents

With over 5000

Employees

Copyright © BGI 2016